In pharmaceutical development, where most therapies never reach the market, early evidence can determine whether a program moves forward or stalls. Yet many teams begin development with limited visibility into how diseases are actually treated in the real world, particularly in therapeutic areas where the organization has little prior experience.
In this webinar with GSK, experts share how their team used real-world claims data to identify risks earlier, uncover treatment patterns, and strengthen evidence generation ahead of launch. You’ll hear how they moved from data scarcity to insight-driven decision making, improving alignment across clinical, medical, and commercial teams.